Beam

Beam is a company that develops gene-editing therapeutics, and also an open-weight AI model designed to rival Chinese models at a lower compute cost.

Why it’s in the news: It is in the news due to a lawsuit filed by its biotech division, Beam Therapeutics, alleging intellectual property theft against a Chinese company.

Latest on Beam

• The Sonos Beam 2 soundbar is $140 off
• Reflection debuts Beam, an open-weight AI model to rival Chinese models at lower compute cost
• DoD demo contract takes a step closer to beaming solar power from space
• STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more
• STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
• China lights up ‘super microscope’ hopes with world-leading electron gun beam
• This new AI model could help America close a technological gap with China
• Nvidia-backed Reflection AI challenges Chinese dominance in open-weight models
• Nvidia-backed Reflection unveils Open AI model, taking on China
• Nvidia-backed startup Reflection unveils open-weight AI model said to rival China offerings

Connections

17 entities linked to Beam across the news graph.